CI

At a glance

ClinicalIndex Comparison Record
N/ARecruiting· 1,500 target
Drug / intervention
Not specified
Likely dose
Not stated in record
Key inclusion· 2
  • Ability to provide informed consent
  • Receiving radiotherapy or brachytherapy
Key exclusion· 0

None specified.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03378856
NCT03378856N/ARecruitingUpdate OverdueUpdated 18mo ago · Completion was 9mo ago
Enrollment Stalled
Long Recruiting
Update Overdue

Partnership Initiative for the Evaluation of Technological Innovation in Radiotherapy

Centre hospitalier de l'Université de Montréal (CHUM)·observational·Posted Dec 20, 2017·Updated Dec 20, 2024

In Brief

An observational study for Cancer and Radiotherapy Side Effect. Currently recruiting, targeting 1,500 participants across 5 sites.

Signals

Enrollment appears stalled

Detailed Summary

Prospective cohort study of patients receiving standard-care radiotherapy is paramount to a better understanding of radiation effects and longterm outcomes. The primary objective is to determine the feasibility of establishing infrastructure to systematically collect clinical data, patient-reported outcomes, and imaging data from daily radiotherapy practice. Secondary objectives are to provide a control cohort for comparative effectiveness research of investigational interventions through a cmRCT design; compare imaging features with clinical outcomes; understand dose-effect relationships; quantify imaging quality metrics.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesCanada
Collaborators--

Timeline

N/ARecruitingOverdue
201820192020202120222023202420252026
First PostedDec 20, 2017
Enrollment StartNov 1, 2017
Primary CompletionOct 1, 2025
TodayJul 2, 2026
Enrollment to primary: 7.9 yearsPosted 8.5 years ago